June 26, 2026 MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease
June 26, 2026 WISeKey’s WISeID Positioned to Benefit from Accelerating Global Transition to Post-Quantum Digital Identity and Authentication Standards
